Knee Cartilage Product Authorized to Restore Defects
WEDNESDAY, Dec. 14, 2016 (HealthDay Information) -- Maci (autologous cultured chondrocytes) has been permitted by the U.S. Meals and Drug Administration to restore faulty cartilage of the knee.
The therapy, derived from wholesome cartilage from the affected person's personal knee, makes use of tissue engineering to develop cells that substitute the broken cartilage, the company stated in a information launch.
Cartilage defects generally stem from an damage, knee pressure, overuse, muscle weak point or normal wear-and-tear, the FDA stated.
The brand new course of makes use of the affected person's personal (autologous) cells, that are positioned on a collagen membrane scaffolding that's surgically implanted over the realm the place broken cartilage was eliminated. The membrane is designed to be absorbed by the physique over time.
The surgeon putting in the implants must be skilled within the Maci product. A number of implants can be utilized if there's a couple of defect, the FDA stated.
Maci's security and effectiveness had been demonstrated throughout a two-year, 144-patient scientific research that in contrast the brand new product to an alternate surgical process. Potential unintended effects of Maci included joint ache, cold-like signs, headache and again ache.
Maci is produced by Vericel Corp., primarily based in Cambridge, Mass.
-- Scott Roberts
Copyright © 2016 HealthDay. All rights reserved.
No comments:
Post a Comment